Navigation Links


Siemens at Biology News

Siemens at Biology Products
Siemens at Biology Technology
Siemens at Medicine News
Siemens at Medicine Products

Stealthstation Siemens Siremobil Iso-C3D C-Arm Imaging System Interface

Description:Stealthstation Siremobil Iso-C3D C-Arm imaging system interface sets a new standard in the field of mobile C-arm imaging. Combining mobility and accurate imaging with Medtronic SNT image-guidance software, the cooperative technologies deliver the most complete perspective to the surgeon. Intra-operative 3D imaging is the new standard in the OR. Medtronic-SNT has taken intraoperative fluoroscop...
Company:Medtronic Surgical Navigation Technologies

Siemens Med Administration Check

Description:Med Administration Check closes the loop on the medication use process by automatically validating and documenting medication administration....
Company:Siemens Medical IT Solutions and Consulting

Siemens Webcast: Cardiovascular Computed Tomography (CVCT): A Cardiologists Perspective

Description:...
Company:Siemens Medical Solutions USA, Inc.

Siemens Webcast: Legislative Developments Impacting Cardiology Services Reimbursement

Description:...
Company:Siemens Medical Solutions USA, Inc.

Siemens Webcast: Expert Insight - Key Elements for a Successful Electrophysiology Program

Description:...
Company:Siemens Medical Solutions USA, Inc.

More>>

Siemens at Medicine Technology
Other TagsChicagoChicagoCompanyCompanyCompanyCompanyLucigenLucigenBiomedicalBiomedicalMirusMirusBrandingFiservAuroraPatentPatent
(Date:7/25/2008)... The Retina Group of New York will present a...r degeneration especially designed for seniors. Th...ibrary at 116 Merritts Road, Farmingdale, NY 11735...ce is free and refreshments will be provided. The ...0. , Hicksville and Haupp...
(Date:7/25/2008)... The Drug Information Association (DIA) and ...he Critical Path Initiative (CPI) on the Move: Com...da, MD) and the Critical Path Transporter Workshop... Horsham, PA (PRWEB) July 25, 2005-- T...ociation (DIA)] and the Food and Drug Administrati...
(Date:7/25/2008)... Columbus-based law firm represents Pickerin...urchased at Columbus-area Kroger store , ...25, 2008 -- http://www.donaheyohioinjurylawyers.c...sonal injury law firms in central Ohio, has filed ...rt (Case No. 08CV9804) against The Kroger Co., in ...
(Date:7/24/2008)... Hoag to lease hospital facility on Sand Can...h, CA (Vocus) July 24, 2008 -- Hoag Memorial Hospi..., Inc. (NYSE: HCP), a Real Estate Investment Trust...-bed hospital facility on Sand Canyon Avenue near ...lity is currently operated by Tenet Healthcare Cor...
Breaking Medicine News(10 mins):Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 3Health News:DIA And FDA To Host Two Important Critical Path Workshops 2Health News:DIA And FDA To Host Two Important Critical Path Workshops 3Health News:Donahey Law Firm Files E. Coli Product Liability Lawsuit Against Kroger Company in Franklin County Court 2Health News:Hoag Hospital Announces Agreement to Open Irvine Campus 2
(Date:7/24/2008)... , July 24, 2008 A new study by researchers from...alth addresses one of the most challenging issues ...V transmission in poor countries. In these settin... the best outcome for their infants, they should e...g four to six months after birth. But according to...
(Date:7/24/2008)... , Irvine, Calif. UC Irvine researchers have f...ur own body clock and metabolism. The discovery r...etes, obesity and other related diseases. , Paol... of Pharmacology, and his colleagues have identifi...ulates the body,s circadian rhythms, works in bala...
(Date:7/24/2008)... , PORTLAND, Ore. July 23, 2008. A fire is curren... were made about fire behavior about 2 years ago. ...ate-Successional Reserve (LSR) study in the planni...r where the Cold Springs fire is now active., Th...de Range in Washington, and covers about 15,000 ac...
(Date:7/23/2008)... , COLUMBUS, Ohio Wealthy nations willing to col...event the emission of roughly half a billion metri...years, new research suggests. , It would take a...he tropical deforestation in the world, one of the...earchers estimate. , If adopted, this type of pr...
Breaking Biology News(10 mins):Early cessation of breastfeeding by HIV+ women in poor countries and child survival 2Early cessation of breastfeeding by HIV+ women in poor countries and child survival 3Circadian rhythm-metabolism link discovered 2Landscape study may offer solutions for fire managers 2Paying to save tropical forests could be a way to reduce global carbon emissions 2Paying to save tropical forests could be a way to reduce global carbon emissions 3Paying to save tropical forests could be a way to reduce global carbon emissions 4Free White Paper Available for Clinical Laboratory Managers 3A Effectively Isolating Anaerobic Bacteria 2686 1Free White Paper Available for Clinical Laboratory Managers 3A Effectively Isolating Anaerobic Bacteria 2686 2Protalix BioTherapeutics Extends Research Agreement With Yissum Based on Promising Acetylcholinesterase Program Results in Animal Study 1242 1Protalix BioTherapeutics Extends Research Agreement With Yissum Based on Promising Acetylcholinesterase Program Results in Animal Study 1242 2Protalix BioTherapeutics Extends Research Agreement With Yissum Based on Promising Acetylcholinesterase Program Results in Animal Study 1242 3iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product 1239 1iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product 1239 2iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product 1239 3iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product 1239 4Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non Small Cell Lung Cancer 1236 1Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non Small Cell Lung Cancer 1236 2Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non Small Cell Lung Cancer 1236 3Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non Small Cell Lung Cancer 1236 4
Other Contentsrepulsionresolutionresolutionresolutionresolutionresolutionresolutionresolutionresolutionresolutionresponseresponseresponseresponseresponseresponseresponseresponseresponseresponseresponsivenessresponsivenessresponsivenessresponsivenessresponsivenessrestingrestingrestingrestingrestingrestingrestingrestingenzymesenzymesenzymesenzymesenzymesenzymesenzymesenzymeslysatelysatereticulocytereticulocyte